The Dublin-based company has received FDA approval for the Evolut PRO+ TAVR System. An analyst with Canaccord Genuity said there would be some key updates from TAVR clinical trials at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 meeting held later this week.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,